Pre-diagnosis neutrophil-to-lymphocyte ratio and mortality in individuals who develop lung cancer
Open Access
- 8 July 2021
- journal article
- research article
- Published by Springer Nature in Cancer Causes & Control
- Vol. 32 (11) , 1227-1236
Abstract
Purpose: The neutrophil-to-lymphocyte ratio (NLR) is a marker of systemic inflammation that has been reported to be associated with survival after chronic disease diagnoses, including lung cancer. We hypothesized that the inflammatory profile reflected by pre-diagnosis NLR, rather than the well-studied pre-treatment NLR at diagnosis, may be associated with increased mortality after lung cancer is diagnosed in high-risk heavy smokers. Methods: We examined associations between pre-diagnosis methylation-derived NLR (mdNLR) and lung cancer-specific and all-cause mortality in 279 non-small lung cancer (NSCLC) and 81 small cell lung cancer (SCLC) cases from the β-Carotene and Retinol Efficacy Trial (CARET). Cox proportional hazards models were adjusted for age, sex, smoking status, pack years, and time between blood draw and diagnosis, and stratified by stage of disease. Models were run separately by histotype. Results: Among SCLC cases, those with pre-diagnosis mdNLR in the highest quartile had 2.5-fold increased mortality compared to those in the lowest quartile. For each unit increase in pre-diagnosis mdNLR, we observed 22–23% increased mortality (SCLC-specific hazard ratio [HR] = 1.23, 95% confidence interval [CI]: 1.02, 1.48; all-cause HR = 1.22, 95% CI 1.01, 1.46). SCLC associations were strongest for current smokers at blood draw (Interaction Ps = 0.03). Increasing mdNLR was not associated with mortality among NSCLC overall, nor within adenocarcinoma (N = 148) or squamous cell carcinoma (N = 115) case groups. Conclusion: Our findings suggest that increased mdNLR, representing a systemic inflammatory profile on average 4.5 years before a SCLC diagnosis, may be associated with mortality in heavy smokers who go on to develop SCLC but not NSCLC.Keywords
All Related Versions
Funding Information
- National Cancer Institute (R01 CA151989, P30 CA042014, P30 CA168524, R01 CA111703, UM1 CA167462, U01 CA63673, U01 CA167462)
- Munck-Pfefferkorn Fund at Dartmouth College
- Huntsman Cancer Foundation
- Kansas IDeA Network of Biomedical Research Excellence Bioinformatics Core
- National Institute of General Medical Sciences (P20 GM103418)
- National Center for Advancing Translational Sciences (TL1 TR002540)
This publication has 68 references indexed in Scilit:
- Circulating Inflammation Markers and Prospective Risk for Lung CancerJNCI: Journal of the National Cancer Institute, 2013
- Epidemiology of Lung CancerChest, 2013
- Neutrophil recruitment and function in health and inflammationNature Reviews Immunology, 2013
- The Relationship Between Chronic Obstructive Pulmonary Disease and Lung Cancer in African American PatientsClinical Lung Cancer, 2012
- Increased Levels of Circulating Interleukin 6, Interleukin 8, C-Reactive Protein, and Risk of Lung CancerJNCI: Journal of the National Cancer Institute, 2011
- Characteristics and Outcomes of Small Cell Lung Cancer Patients Diagnosed During Two Lung Cancer Computed Tomographic Screening Programs in Heavy SmokersJournal of Thoracic Oncology, 2011
- Role of emphysema and airway obstruction in prognosis of lung cancerLung Cancer, 2011
- Risk Factors for Lung Cancer and for Intervention Effects in CARET, the Beta-Carotene and Retinol Efficacy TrialJNCI: Journal of the National Cancer Institute, 1996
- Proportional hazards tests and diagnostics based on weighted residualsBiometrika, 1994
- Hyperpigmentation in the long bones of the lower limbs as a basis for vehicle identification and traffic accident reconstructionForensic Science International, 1982